The Bioinformatics CRO Podcast
Episode 69 with David Scieszka
David Scieszka, founder and CEO of Vertical Longevity Pharmaceuticals, tells us about VeLo’s pioneering senolytic vaccine approach to clearing senescent cells and his quest for longer, healthier lives for everyone.
On The Bioinformatics CRO Podcast, we sit down with scientists to discuss interesting topics across biomedical research and to explore what made them who they are today.
You can listen on Spotify, Apple Podcasts, Amazon, YouTube, Pandora, and wherever you get your podcasts.
David Scieszka is founder and CEO of Vertical Longevity Pharma, which is currently pioneering a senolytic vaccine approach to targeting atherosclerosis and aging.
VeLo Pharma has just opened up a community investment round with no investor accreditation required: https://netcapital.com/companies/vertical-longevity
Transcript of Episode 69: David Scieszka
Disclaimer: Transcripts may contain errors.